These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36330436)

  • 21. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
    Meijing Z; Tianhang L; Biao Y
    Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
    [No Abstract]   [Full Text] [Related]  

  • 22. Significance of RNA N6-Methyladenosine Regulators in the Diagnosis and Subtype Classification of Childhood Asthma Using the Gene Expression Omnibus Database.
    Dai B; Sun F; Cai X; Li C; Liu H; Shang Y
    Front Genet; 2021; 12():634162. PubMed ID: 33763115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
    Ouyang X; Gong Y
    Front Immunol; 2022; 13():912526. PubMed ID: 35720276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology of hypersensitivity pneumonitis.
    Takemura T; Akashi T; Ohtani Y; Inase N; Yoshizawa Y
    Curr Opin Pulm Med; 2008 Sep; 14(5):440-54. PubMed ID: 18664975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms.
    Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M
    Front Neurol; 2022; 13():889141. PubMed ID: 35989938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis.
    Ye F; Wang T; Wu X; Liang J; Li J; Sheng W
    J Transl Med; 2021 Jul; 19(1):316. PubMed ID: 34294105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study.
    Sobiecka M; Szturmowicz M; Lewandowska K; Kowalik A; Łyżwa E; Zimna K; Barańska I; Jakubowska L; Kuś J; Langfort R; Tomkowski W
    BMC Pulm Med; 2021 Dec; 21(1):416. PubMed ID: 34920701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
    Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
    Front Oncol; 2021; 11():726018. PubMed ID: 35299934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers.
    Tan S; Li Z; Li K; Li Y; Liang G; Tang Z; Kang J; Chen W; Li M; Zou Z; Pi G; Zhu X
    Front Cell Dev Biol; 2022; 10():843275. PubMed ID: 35356280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas.
    Xu S; Tang L; Dai G; Luo C; Liu Z
    Front Cell Dev Biol; 2020; 8():594112. PubMed ID: 33240891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
    Hao X; Li Y; Huang G; Zeng Y
    Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
    Quan Y; Zhang X; Ping H
    Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis.
    Hasan SA; Eksteen B; Reid D; Paine HV; Alansary A; Johannson K; Gwozd C; Goring KA; Vo T; Proud D; Kelly MM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1663-73. PubMed ID: 23453796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
    Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
    Front Genet; 2021; 12():752025. PubMed ID: 35046996
    [No Abstract]   [Full Text] [Related]  

  • 36. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
    Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
    Front Immunol; 2021; 12():789914. PubMed ID: 34887874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
    Chen K; Zhu S; Yu W; Xia Y; Xing J; Geng J; Cheng F
    Front Oncol; 2022; 12():908832. PubMed ID: 35600386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis.
    Deng MS; Chen KJ; Zhang DD; Li GH; Weng CM; Wang JM
    Evid Based Complement Alternat Med; 2022; 2022():2425065. PubMed ID: 35497924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling pathways and their miRNA regulators involved in the etiopathology of idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis (HP).
    Kiszałkiewicz J; Piotrowski W; Brzeziańska-Lasota E
    Adv Respir Med; 2017; 85(3):169-178. PubMed ID: 28667660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.